Maven Capital Partners
Venture capital firm based in London, UK
Maven Capital Partners Investments
Maven Capital Partners has invested in these startups.
Laverock Therapeutics
Laverock Therapeutics secures £13.5M in Seed funding to advance its groundbreaking gene silencing platform and drive advancements in regenerative medicine and immuno-oncology. Read more
Drovo
London-based transit media advertising technology company Drovo has raised £3m in funding to further develop its dynamic digital rooftop screens and expand its human resources, offering targeted and measurable out-of-home advertising campaigns to vehicle owners while providing valuable insights into impressions, reach, and campaign success. Read more
Metrion Biosciences
Cambridge-based Metrion Biosciences secures £3.7M in funding for expansion and enhanced drug discovery capabilities, highlighting the growing demand for ion channel drug discovery services and the company's commitment to advancing research and innovation. Read more
AMufacture
AMufacture secures £1.05 million investment to meet growing demand for its additive manufacturing services and expand its 3D printing capabilities. Read more
Carcinotech
Edinburgh-based Carcinotech secures £4.2m funding to advance revolutionary 3D printed micro-tumour technology, revolutionizing drug screening and improving cancer treatment. Read more
Zing
London-based Twilio consulting partner, Zing, secures £1.25M in funding from Maven Capital Partners to fuel their expansion into the US market and revolutionize customer experiences globally. Read more
Real World Health
Real World Health secures £1.7M in funding to revolutionize healthcare analytics with AI technology, expanding its reach and impact in the industry under CEO Scott Fletcher's leadership. Read more
Connected Data
In a game-changing move for the UK’s financial sector, Maven Capital Partners just dropped £2.2 million into Connected Data, revolutionizing debt management with cutting-edge tech solutions! Read more
Dxcover
Revolutionizing cancer detection, Glasgow's Dxcover secures £9.7 million to propel its groundbreaking liquid biopsy technology for early-stage diagnosis, with a mission to save lives and redefine patient outcomes! Read more
Kani Payments
Maven Capital Partners injects millions into Kani Payments, empowering global expansion and innovation in payment solutions! Read more
Gensyn
London-based Gensyn secures £33.8m in Series A funding to develop its Machine Learning Compute Protocol, a decentralised artificial intelligence creation system that aims to connect all of the world's computing devices into a global super-cluster accessible to all. Read more
Podfather
Edinburgh's Podfather secures £3.4 million investment to enhance fleet operations with cutting-edge logistics software. Watch this space! Read more
Sitehop
Sitehop revolutionizes networking encryption with £5M Seed funding, paving the way for global expansion and cutting-edge cybersecurity solutions. Read more
Investments By Sector
Maven Capital Partners has invested in these sectors
| Healthtech | 33.3% |
| Fintech | 20.0% |
| Biotech | 13.3% |
| SaaS | 13.3% |
| Media | 6.7% |
| AI | 6.7% |
| Cyber security | 6.7% |
